Status:
COMPLETED
Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section
Lead Sponsor:
Attikon Hospital
Conditions:
Surgical Site Infections
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
The efficacy and safety of a single dose of ampicillin/sulbactam compared to a single dose of cefuroxime at cord clamp for prevention of postcesarean infectious morbidity has not been assessed. Women...
Detailed Description
The efficacy and safety of a single dose of ampicillin/sulbactam compared to a single dose of cefuroxime at cord clamp for prevention of postcesarean infectious morbidity has not been assessed. The i...
Eligibility Criteria
Inclusion
- \- All patients undergoing a cesarean delivery were eligible.
Exclusion
- Patients with known hypersensitivity to penicillin or cephalosporins.
- Patients who required concomitant antibiotic therapy during surgery.
- Patients who have received antibiotics during the 72 hours immediately preceding their enrollment.
- Patients whose postpartum fever was clearly associated with other known causes.
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT01138852
Start Date
July 1 2004
End Date
December 1 2008
Last Update
June 7 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.